Veuillez trouver ci-dessous les publications scientifiques, recensées par la filière, en lien avec les maladies respiratoires rares, classées par groupe de pathologies.

Predicting the risk of respiratory distress in newborns with congenital pulmonary malformations

Delacourt C, Bertille N, Salomon LJ, Rashenas M, Benachi A, Bonnard A, Choupeaux L, Fouquet V, Goua V, Hameury F, Hervieux E, Jouannic JM, Khen-Dunlop N, Le Bouar G, Massardier J, Roditis L, Rosenblatt J, Sartor A, Thong-Vanh C, Lelong N, Khoshnood B; MALFPULM study group.
Eur Respir J. 2021 Jul 15:2100949. Doi: 10.1183/13993003.00949-2021.

Thoracoscopic surgery for congenital lung malformations : Does previous infection really matter ?

Elhattab A, Elsaied A, Wafa T, Jugie M, Delacourt C, Sarnacki S, Aly K, Khen-Dunlop N.
J Pediatr Surg. 2021 Jan 27: S0022-3468(21)00086-5. Doi: 10.1016/j.jpedsurg.2021.01.036.

Intravenous pulses of methylprednisolone for infants with severe bronchopulmonary dysplasia and respiratory support after 3 months of age

Billion E, Hadchouel A, Garcelon N, Delacourt C, Drummond D.
Pediatr Pulmonol. 2021 Jan;56(1):74-82. Doi: 10.1002/ppul.25109.

Management of early infection with Pseudomonas aeruginosa in adults with bronchiectasis: A survey of French pulmonologist’s practices

Schlemmer F, Murris-Espin M, Douvry B, Bergeron A, Burgel PR, Andrejak C, Maitre B.
Respir Med Res. 2021 Sep 9;80:100859. Doi: 10.1016/j.resmer.2021.100859.

Robotic lobectomy in children with severe bronchiectasis: A worthwhile new technology

Durand M, Musleh L, Vatta F, Orofino G, Querciagrossa S, Jugie M, Bustarret O, Delacourt C, Sarnacki S, Blanc T, Khen-Dunlop N.
J Pediatr Surg. 2021 Sep;56(9):1606-1610. Doi: 10.1016/j.jpedsurg.2020.11.009.

European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis

Chang AB, Fortescue R, Grimwood K, Alexopoulou E, Bell L, Boyd J, Bush A, Chalmers JD, Hill AT, Karadag B, Midulla F, McCallum GB, Powell Z, Snijders D, Song WJ, Tonia T, Wilson C, Zacharasiewicz A, Kantar A.
Eur Respir J. 2021 Aug 26;58(2):2002990. Doi: 10.1183/13993003.02990-2020.

Ciliary Videomicroscopy: A Long Beat from the European Respiratory Society Guidelines to the Recognition as a Confirmatory Test for Primary Ciliary Dyskinesia

Bricmont N, Alexandru M, Louis B, Papon JF, Kempeneers C.
Diagnostics (Basel). 2021 Sep 17;11(9):1700. Doi: 10.3390/diagnostics11091700.

Etiological Work-Up for Adults with Bronchiectasis: A Predictive Diagnostic Score for Primary Ciliary Dyskinesia and Cystic Fibrosis

Schlemmer F, Hamzaoui A, Zebachi S, Le Thuaut A, Mangiapan G, Monnet I, Boudjema A, Jabot L, Housset B, Bastuji-Garin S, Bassinet L, Maitre B.
J Clin Med. 2021 Aug 6;10(16):3478. Doi: 10.3390/jcm10163478.

Topological data analysis reveals genotype-phenotype relationships in primary ciliary dyskinesia

Shoemark A, Rubbo B, Legendre M, Fassad MR, Haarman EG, Best S, Bon ICM, Brandsma J, Burgel PR, Carlsson G, Carr SB, Carroll M, Edwards M, Escudier E, Honoré I, Hunt D, Jouvion G, Loebinger MR, Maitre B, Morris-Rosendahl D, Papon JF, Parsons CM, Patel MP, Thomas NS, Thouvenin G, Walker WT, Wilson R, Hogg C, Mitchison HM, Lucas JS.
Eur Respir J. 2021 Aug 5;58(2):2002359. Doi: 10.1183/13993003.02359-2020.

International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives

Marthin JK, Lucas JS, Boon M, Casaulta C, Crowley S, Destouches DMS, Eber E, Escribano A, Haarman E, Hogg C, Maitre B, Marsh G, Martinu V, Moreno-Galdó A, Mussaffi H, Omran H, Pohunek P, Rindlisbacher B, Robinson P, Snijders D, Walker WT, Yiallouros P, Johansen HK, Nielsen KG.
ERJ Open Res. 2021 Aug 2;7(3):00301-2021. Doi: 10.1183/23120541.00301-2021.

Breath-holding and tidal breathing nasal NO to screen children for Primary Ciliary Dyskinesia

Beydon N, Tamalet A, Escudier E, Legendre M, Thouvenin G.
Pediatr Pulmonol. 2021 Jul;56(7):2242-2249. Doi: 10.1002/ppul.25432.

Motile cilia and airway disease
Legendre M, Zaragosi LE, Mitchison HM.
Semin Cell Dev Biol. 2021 Feb;110:19-33. Doi: 10.1016/j.semcdb.2020.11.007.

Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden

Lancaster L, Bonella F, Inoue Y, Cottin V, Siddall J, Small M, Langley J.
Respirology. 2021 Oct 5. Doi: 10.1111/resp.14154.

Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss

Jouneau S, Crestani B, Thibault R, Lederlin M, Vernhet L, Yang M, Morgenthien E, Kirchgaessler KU, Cottin V.
Respiration. 2021 Oct 5:1-13. Doi: 10.1159/000518855

The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis

Zinellu A, Collu C, Nasser M, Paliogiannis P, Mellino S, Zinellu E, Traclet J, Ahmad K, Mangoni AA, Carru C, Pirina P, Fois AG, Cottin V.
J Clin Med. 2021 Sep 14;10(18):4134. Doi: 10.3390/jcm10184134.

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H; EXAFIP investigators and the OrphaLung network.
Lancet Respir Med. 2021 Sep 7: S2213-2600(21)00354-4. Doi: 10.1016/S2213-2600(21)00354-4.

Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD Cohort

Cottin V, Gueguen S, Jouneau S, Nunes H, Crestani B, Bonniaud P, Wémeau-Stervinou L, Reynaud-Gaubert M, Israël-Biet D, Cadranel J, Marchand-Adam S, Quétant S, Hirschi S, Montani D, Gamez AS, Chevereau M, Dufaure-Garé I, Amselem S, Clement A; OrphaLung and RespiFil Networks.
Respiration. 2021 Sep 2:1-12. Doi: 10.1159/000518008.

Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial

Flaherty KR, Wells AU, Cottin V, Devaraj A, Inoue Y, Richeldi L, Walsh SLF, Kolb M, Koschel D, Moua T, Stowasser S, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD trial investigators.
Eur Respir J. 2021 Sep 2:2004538. Doi: 10.1183/13993003.04538-2020.

Inhibition of the Arp2/3 complex represses human lung myofibroblast differentiation and attenuates bleomycin-induced pulmonary fibrosis

Mergault C, Lisée F, Tiroille V, Magnien M, Parent C, Lenga Mabonda W, Sizaret D, Jaillet M, Crestani B, Marchand-Adam S, Plantier L.
Br J Pharmacol. 2021 Aug 28. Doi: 10.1111/bph.15675.

Air pollution and poverty: a deadly mix in idiopathic pulmonary fibrosis ?

Sesé L, Annesi-Maesano I, Cavalin C, Nunes H.
Eur Respir J. 2021 Aug 12:2101714. Doi: 10.1183/13993003.01714-2021.

Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal ?

Sesé L, Nunes H, Cottin V, Israel-Biet D, Crestani B, Guillot-Dudoret S, Cadranel J, Wallaert B, Tazi A, Maître B, Prévot G, Marchand-Adam S, Hirschi S, Dury S, Giraud V, Gondouin A, Bonniaud P, Traclet J, Juvin K, Borie R, Carton Z, Freynet O, Gille T, Planès C, Valeyre D, Uzunhan Y.
Front Med (Lausanne). 2021 Aug 5;8:713698. Doi: 10.3389/fmed.2021.713698.

Usefulness of Body Composition CT Analysis in Patients with Idiopathic Pulmonary Fibrosis : A Pilot Study

Jalaber C, Lemerre-Poincloux J, Jouneau S, Rousseau C, Dolou B, Rouag E, Lescoat A, Luque-Paz D, Lucas C, Vernhet L, Thibault R, Lederlin M.
Acad Radiol. 2021 Aug 17: S1076-6332(21)00328-7. Doi: 10.1016/j.acra.2021.07.020.

Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial

Noth I, Cottin V, Chaudhuri N, Corte TJ, Johannson KA, Wijsenbeek M, Jouneau S, Michael A, Quaresma M, Rohr KB, Russell AM, Stowasser S, Maher TM; INMARK trial investigators.
Eur Respir J. 2021 Jul 8;58(1):2001518. Doi: 10.1183/13993003.01518-2020.

Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover

Sesé L, Caliez J, Annesi-Maesano I, Cottin V, Pesce G, Didier M, Carton Z, Israel-Biet D, Crestani B, Dudoret SG, Cadranel J, Wallaert B, Tazi A, Maître B, Prévot G, Marchand-Adam S, Hirschi S, Dury S, Giraud V, Gondouin A, Bonniaud P, Traclet J, Juvin K, Borie R, Bernaudin JF, Valeyre D, Cavalin C, Nunes H; COFI collaborators.
Respir Med. 2021 Jul;183:106415. Doi: 10.1016/j.rmed.2021.106415.

Response to letter entitled: Re: Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis

Duchemann B, Pluvy J, Crestani B, Zalcman G, Nunes H.
Eur J Cancer. 2021 Jul;151:252-253. Doi: 10.1016/j.ejca.2021.04.001

Prevalence, predicting factors and impact of internet use by patients with idiopathic pulmonary fibrosis: A cross-sectional observational study

Le Garrec M, Rousseau C, Thépault F, Kerjouan M, Salé A, Jouneau S.
Respir Med Res. 2021 May;79:100818. Doi: 10.1016/j.resmer.2021.100818.

Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis

Duchemann B, Pluvy J, Crestani B, Zalcman G, Nunes H.
Eur J Cancer. 2021 Mar;145:179-182. Doi: 10.1016/j.ejca.2020.12.016.

Regulation of immune cells in lung fibrosis: the reign of regnase-1 ?

Froidure A, Crestani B.
Eur Respir J. 2021 Mar 11;57(3):2004029. Doi: 10.1183/13993003.04029-2020.

Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation

Justet A, Klay D, Porcher R, Cottin V, Ahmad K, Molina Molina M, Nunes H, Reynaud-Gaubert M, Naccache JM, Manali E, Froidure A, Jouneau S, Wemeau L, Andrejak C, Gondouin A, Hirschi S, Blanchard E, Bondue B, Bonniaud P, Tromeur C, Prévot G, Marchand-Adam S, Funke-Chambour M, Gamez AS, Ba I, Papiris S, Grutters J, Crestani B, van Moorsel C, Kannengiesser C, Borie R; OrphaLung Network.
Eur Respir J. 2021 Feb 11;57(2):2003198. Doi: 10.1183/13993003.03198-2020.

IC4 : a new combined predictive index of mortality in idiopathic pulmonary fibrosis

Zinellu A, Collu C, Zinellu E, Ahmad K, Nasser M, Traclet J, Sotgiu E, Mellino S, Mangoni AA, Carru C, Pirina P, Cottin V, Fois AG.
Panminerva Med. 2021 Jan 26. Doi: 10.23736/S0031-0808.21.04144-6.

NADPH oxidase DUOX1 sustains TGF-β1 signalling and promotes lung fibrosis

Louzada RA, Corre R, Ameziane El Hassani R, Meziani L, Jaillet M, Cazes A, Crestani B, Deutsch E, Dupuy C.
Eur Respir J. 2021 Jan 14;57(1):1901949. Doi: 10.1183/13993003.01949-2019.

Pulmonary hypertension : A rare but severe complication of common variable immunodeficiency

Thoré P, Humbert M, Montani D.
Ann Allergy Asthma Immunol. 2021 Oct;127(4):512-513. Doi: 10.1016/j.anai.2021.06.016.

Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension

Boucly A, Savale L, Jaïs X, Bauer F, Bergot E, Bertoletti L, Beurnier A, Bourdin A, Bouvaist H, Bulifon S, Chabanne C, Chaouat A, Cottin V, Dauphin C, Degano B, De Groote P, Favrolt N, Feng Y, Horeau-Langlard D, Jevnikar M, Jutant EM, Liang Z, Magro P, Mauran P, Moceri P, Mornex JF, Palat S, Parent F, Picard F, Pichon J, Poubeau P, Prévot G, Renard S, Reynaud-Gaubert M, Riou M, Roblot P, Sanchez O, Seferian A, Tromeur C, Weatherald J, Simonneau G, Montani D, Humbert M, Sitbon O.
Am J Respir Crit Care Med. 2021 Oct 1;204(7):842-854. Doi: 10.1164/rccm.202009-3698OC.

Pulmonary Hypertension in Patients with Common Variable Immunodeficiency

Thoré P, Jaïs X, Savale L, Dorfmuller P, Boucly A, Devilder M, Meyrignac O, Pichon J, Mankikian J, Riou M, Boiffard E, Boissin C, De Groote P, Chabanne C, Gagnadoux F, Bergeron A, Noel N, Sitbon O, Humbert M, Montani D.
J Clin Immunol. 2021 Oct;41(7):1549-1562. Doi: 10.1007/s10875-021-01064-w.

Investigating the association between ALK Receptor Tyrosine Kinase inhibitors and pulmonary arterial hypertension: a disproportionality analysis from the WHO pharmacovigilance database

Khouri C, Hlavaty A, Roustit M, Cracowski JL, Chaumais MC, Humbert M, Montani D.
Eur Respir J. 2021 Sep 29:2101576. Doi: 10.1183/13993003.01576-2021.

Mendelian randomisation and experimental medicine approaches to IL-6 as a drug target in PAH

Toshner M, Church C, Harbaum L, Rhodes C, Villar Moreschi SS, Liley J, Jones R, Arora A, Batai K, Desai AA, Coghlan JG, Gibbs JSR, Gor D, Gräf S, Harlow L, Hernandez-Sanchez J, Howard LS, Humbert M, Karnes J, Kiely DG, Kittles R, Knightbridge E, Lam B, Lutz KA, Nichols WC, Pauciulo MW, Pepke-Zaba J, Suntharalingam J, Soubrier F, Trembath RC, Schwantes-An TL, Wort SJ, Wilkins M, Gaine S, Morrell NW, Corris PA.
Eur Respir J. 2021 Sep 29:2002463. Doi: 10.1183/13993003.02463-2020.

Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure

Savale L, Vuillard C, Pichon J, Boucly A, Roche A, Jevnikar M, Ebstein N, Jaïs X, Le Pavec J, Montani D, Mercier O, Sitbon O, Fadel E, Humbert M.
Eur Respir J. 2021 Sep 23;58(3):2100466. Doi: 10.1183/13993003.00466-2021.

Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort

Dauriat G, Reynaud-Gaubert M, Cottin V, Lamia B, Montani D, Canuet M, Boissin C, Tromeur C, Chaouat A, Degano B, Bergot E, Sanchez O, Prevot G, Sitbon O, Thabut G, Belhadi D, de Beauregard YC, Bencherif A, Humbert M, Simonneau G, Laouenan C, Mal H.
J Heart Lung Transplant. 2021 Sep;40(9):1009-1018. Doi: 10.1016/j.healun.2021.04.021.

A CELSR1 variant in a patient with pulmonary arterial hypertension

Eyries M, Girerd B, Savale L, Soubrier F, Humbert M, Montani D.
Clin Genet. 2021 Aug 25. Doi: 10.1111/cge.14046.

Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension

Bisserier M, Katz MG, Bueno-Beti C, Brojakowska A, Zhang S, Gubara S, Kohlbrenner E, Fazal S, Fargnoli A, Dorfmuller P, Humbert M, Hata A, Goukassian DA, Sassi Y, Hadri L.
Int J Mol Sci. 2021 Aug 24;22(17):9105. Doi: 10.3390/ijms22179105.

Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension: Implications for Therapy

Lechartier B, Berrebeh N, Huertas A, Humbert M, Guignabert C, Tu L.
Chest. 2021 Aug 12: S0012-3692(21)03667-9. Doi: 10.1016/j.chest.2021.08.040.

Serum and pulmonary uric acid in pulmonary arterial hypertension

Savale L, Akagi S, Tu L, Cumont A, Thuillet R, Phan C, Le Vely B, Berrebeh N, Huertas A, Jaïs X, Cottin V, Chaouat A, Tromeur C, Boucly A, Jutant EM, Mercier O, Fadel E, Montani D, Sitbon O, Humbert M, Tamura Y, Guignabert C.
Eur Respir J. 2021 Aug 5;58(2):2000332. Doi: 10.1183/13993003.00332-2020.

Association between Leflunomide and Pulmonary Hypertension

Palasset TL, Chaumais MC, Weatherald J, Savale L, Jaïs X, Price LC, Khouri C, Bulifon S, Seferian A, Jevnikar M, Boucly A, Manaud G, Pancic S, Chabanne C, Ahmad K, Volpato M, Favrolt N, Guillaumot A, Horeau-Langlard D, Prévot G, Fesler P, Bertoletti L, Reynaud-Gaubert M, Lamblin N, Launay D, Simonneau G, Sitbon O, Perros F, Humbert M, Montani D.
Ann Am Thorac Soc. 2021 Aug;18(8):1306-1315. Doi: 10.1513/AnnalsATS.202008-913OC.

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation

Montani D, Girerd B, Jaïs X, Laveneziana P, Lau EMT, Bouchachi A, Hascoët S, Günther S, Godinas L, Parent F, Guignabert C, Beurnier A, Chemla D, Hervé P, Eyries M, Soubrier F, Simonneau G, Sitbon O, Savale L, Humbert M.
Eur Respir J. 2021 Jul 22;58(1):2004229. Doi: 10.1183/13993003.04229-2020.

Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension

Bisserier M, Mathiyalagan P, Zhang S, Elmastour F, Dorfmüller P, Humbert M, David G, Tarzami S, Weber T, Perros F, Sassi Y, Sahoo S, Hadri L.
Circulation. 2021 Jul 6;144(1):52-73. Doi: 10.1161/CIRCULATIONAHA.120.047978.

Pulmonary hypertension associated with neurofibromatosis type 2

Taniguchi H, Takashima T, Tu L, Thuillet R, Furukawa A, Furukawa Y, Kawamura A, Humbert M, Guignabert C, Tamura Y.
Pulm Circ. 2021 Jul 5;11(3):20458940211029550. Doi: 10.1177/20458940211029550.

Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in France

Le Pavec J, Feuillet S, Mercier O, Pauline P, Dauriat G, Crutu A, Florea V, Savale L, Levy M, Laverdure F, Stephan F, Fabre D, Delphine M, Boulate D, Mussot S, Hascoët S, Bonnet D, Humbert M, Fadel E.
J Heart Lung Transplant. 2021 Jul;40(7):652-661. Doi: 10.1016/j.healun.2021.03.013.

Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure

Hautbergue T, Antigny F, Boët A, Haddad F, Masson B, Lambert M, Delaporte A, Menager JB, Savale L, Pavec JL, Fadel E, Humbert M, Junot C, Fenaille F, Colsch B, Mercier O.
Cells. 2021 Jun 21;10(6):1559. Doi: 10.3390/cells10061559.

ERS statement on chronic thromboembolic pulmonary hypertension

Delcroix M, Torbicki A, Gopalan D, Sitbon O, Klok FA, Lang I, Jenkins D, Kim NH, Humbert M, Jais X, Vonk Noordegraaf A, Pepke-Zaba J, Brénot P, Dorfmuller P, Fadel E, Ghofrani HA, Hoeper MM, Jansa P, Madani M, Matsubara H, Ogo T, Grünig E, D’Armini A, Galie N, Meyer B, Corkery P, Meszaros G, Mayer E, Simonneau G.
Eur Respir J. 2021 Jun 17;57(6):2002828. Doi: 10.1183/13993003.02828-2020.

Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10

Bouvard C, Tu L, Rossi M, Desroches-Castan A, Berrebeh N, Helfer E, Roelants C, Liu H, Ouarne M, Chaumontel N, Mallet C, Battail C, Bikfalvi A, Humbert M, Savale L, Daubon T, Perret P, Tillet E, Guignabert C, Bailly S.
Cardiovasc Res. 2021 Jun 4: cvab187. Doi: 10.1093/cvr/cvab187.

The isobaric pulmonary arterial compliance in pulmonary hypertension

Chemla D, Berthelot E, Weatherald J, Lau EMT, Savale L, Beurnier A, Montani D, Sitbon O, Attal P, Boulate D, Assayag P, Humbert M, Hervé P.
ERJ Open Res. 2021 May 31;7(2):00941-2020. Doi: 10.1183/23120541.00941-2020.

Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension

Le Ribeuz H, To L, Ghigna MR, Martin C, Nagaraj C, Dreano E, Rucker-Martin C, Girerd B, Bouliguan J, Pechoux C, Lambert M, Boet A, Issard J, Mercier O, Hoetzenecker K, Manoury B, Becq F, Burgel PR, Cottart CH, Olschewski A, Sermet-Gaudelus I, Perros F, Humbert M, Montani D, Antigny F.
Eur Respir J. 2021 May 28:2000653. Doi: 10.1183/13993003.00653-2020.

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Godinas L, Iyer K, Meszaros G, Quarck R, Escribano-Subias P, Vonk Noordegraaf A, Jansa P, D’Alto M, Luknar M, Milutinov Ilic S, Belge C, Sitbon O, Reis A, Rosenkranz S, Pepke-Zaba J, Humbert M, Delcroix M.
Orphanet J Rare Dis. 2021 May 1;16(1):196. Doi: 10.1186/s13023-021-01752-1.

Inhaled Treprostinil in Group 3 Pulmonary Hypertension

Nasser M, Kolb M, Cottin V.
N Engl J Med. 2021 May 13;384(19):1869. Doi: 10.1056/NEJMc2103465.

Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension

Chaumais MC, Djessas MRA, Thuillet R, Cumont A, Tu L, Hebert G, Gaignard P, Huertas A, Savale L, Humbert M, Guignabert C.
Cardiovasc Res. 2021 Apr 23;117(5):1391-1401. Doi: 10.1093/cvr/cvaa200.

Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs

Valentin S, Maurac A, Sitbon O, Beurnier A, Gomez E, Guillaumot A, Textoris L, Fay R, Savale L, Jaïs X, Montani D, Picard F, Mornex JF, Prevot G, Chabot F, Humbert M, Chaouat A.
Eur Respir J. 2021 Apr 19:2004066. Doi: 10.1183/13993003.04066-2020.

Transplantation for pulmonary arterial hypertension with congenital heart disease: Impact on outcomes of the current therapeutic approach including a high-priority allocation program

Hascoët S, Pontailler M, Le Pavec J, Savale L, Mercier O, Fabre D, Mussot S, Simonneau G, Jais X, Feuillet S, Stephan F, Cohen S, Bonnet D, Humbert M, Dartevelle P, Fadel E.
Am J Transplant. 2021 Apr 12. Doi: 10.1111/ajt.16600.

Sotatercept for the Treatment of Pulmonary Arterial Hypertension

Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman A, Escribano Subias P, Feldman J, Meyer G, Montani D, Olsson KM, Manimaran S, Barnes J, Linde PG, de Oliveira Pena J, Badesch DB; PULSAR Trial Investigators.
N Engl J Med. 2021 Apr 1;384(13):1204-1215. Doi: 10.1056/NEJMoa2024277.

Preoperative C-reactive protein predicts early postoperative outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension

Arthur Ataam J, Amsallem M, Guihaire J, Haddad F, Lamrani L, Stephan F, Jaïs X, Humbert M, Mercier O, Fadel E.
J Thorac Cardiovasc Surg. 2021 Apr;161(4):1532-1542.e5. Doi: 10.1016/j.jtcvs.2019.11.133.

Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension : a pilot study

Jutant EM, Montani D, Sattler C, Günther S, Sitbon O, Garcia G, Arnulf I, Humbert M, Similowski T, Redolfi S.
Pulm Circ. 2021 Mar 30;11(2):2045894021996930. Doi: 10.1177/2045894021996930.

An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension

Ryanto GRT, Ikeda K, Miyagawa K, Tu L, Guignabert C, Humbert M, Fujiyama T, Yanagisawa M, Hirata KI, Emoto N.
Nat Commun. 2021 Mar 19;12(1):1720. Doi: 10.1038/s41467-021-21961-3.

Risk Stratification in Pulmonary Arterial Hypertension : Do Not Forget the Patient Perspective

Humbert M, Lau EMT
Am J Respir Crit Care Med. 2021 Mar 15;203(6):675-677. Doi: 10.1164/rccm.202012-4350ED.

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Ghofrani HA, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberá JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Hoeper MM; NEW COLLABORATORS LIST.
Respir Med. 2021 Mar;178:106220. Doi: 10.1016/j.rmed.2020.106220.

Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.

Certain MC, Chaumais MC, Jaïs X, Savale L, Seferian A, Parent F, Georges M, Favrolt N, Bourdin A, Boissin C, Cottin V, Traclet J, Renard S, Noel V, Picard F, Girerd B, Ghigna MR, Perros F, Sitbon O, Bonniaud P, Humbert M, Montani D.
Chest. 2021 Mar;159(3):1197-1207. Doi: 10.1016/j.chest.2020.09.238.

Reversible pulmonary hypertension associated with multivisceral Whipple’s disease

Camboulive A, Jutant EM, Savale L, Jaïs X, Sitbon O, Mussini C, Bénichou J, Lagier JC, Humbert M, Montani D.
Eur Respir J. 2021 Feb 25;57(2):2003132. Doi: 10.1183/13993003.03132-2020.

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance ?

Weatherald J, Boucly A, Savale L, Jaïs X, Montani D, Humbert M, Sitbon O.
Am J Respir Crit Care Med. 2021 Feb 15;203(4):524-525. Doi: 10.1164/rccm.202009-3664LE.

Targeting transforming growth factor-β receptors in pulmonary hypertension

Guignabert C, Humbert M.
Eur Respir J. 2021 Feb 4;57(2):2002341. Doi: 10.1183/13993003.02341-2020.

Pulmonary arterial hypertension in systemic sclerosis

Lechartier B, Humbert M.
Presse Med. 2021 Feb 3;50(1):104062. Doi: 10.1016/j.lpm.2021.104062.

Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis : Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease

Chauvelot L, Gamondes D, Berthiller J, Nieves A, Renard S, Catella-Chatron J, Ahmad K, Bertoletti L, Camara B, Gomez E, Launay D, Montani D, Mornex JF, Prévot G, Sanchez O, Schott AM, Subtil F, Traclet J, Turquier S, Zeghmar S, Habib G, Reynaud-Gaubert M, Humbert M, Cottin V.
Arthritis Rheumatol. 2021 Feb;73(2):295-304. Doi: 10.1002/art.41512.

Kcnk3 Dysfunction Exaggerates The Development Of Pulmonary Hypertension Induced By Left Ventricular Pressure Overload

Lambert M, Mendes-Ferreira P, Ghigna MR, LeRibeuz H, Adão R, Boet A, Capuano V, Rucker-Martin C, Brás-Silva C, Quarck R, Domergue V, Vachiéry JL, Humbert M, Perros F, Montani D, Antigny F.
Cardiovasc Res. 2021 Jan 23: cvab016. Doi: 10.1093/cvr/cvab016.

Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systems

Jevnikar M, Montani D, Savale L, Seferian A, Jutant EM, Boucly A, Preda M, Weatherald J, Bulifon S, Parent F, Brenot P, Fadel E, Sitbon O, Simonneau G, Humbert M, Jaïs X.
Eur Respir J. 2021 Jan 21;57(1):2002208. Doi: 10.1183/13993003.02208-2020.

Sleep-related breathing disorders and pulmonary hypertension

Adir Y, Humbert M, Chaouat A.
Eur Respir J. 2021 Jan 5;57(1):2002258. Doi: 10.1183/13993003.02258-2020.

Riociguat treatment in patients with pulmonary arterial hypertension : Final safety data from the EXPERT registry

Hoeper MM, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberà JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Ghofrani HA; Collaborators list.
Respir Med. 2020 Dec 3;177:106241. Doi: 10.1016/j.rmed.2020.106241.

Tuberous sclerosis complex for the pulmonologist

Rebaine Y, Nasser M, Girerd B, Leroux C, Cottin V.
Eur Respir Rev. 2021 Aug 3;30(161):200348. Doi: 10.1183/16000617.0348-2020.

Combined pulmonary fibrosis and emphysema in alpha-1-antitrypsin deficiency

Le Beller A, Nasser M, Traclet J, Blanchet-Legens AS, Kannengiesser C, Mornex JF, Cottin V.
Respir Med Res. 2021 May;79:100819. Doi: 10.1016/j.resmer.2021.100819.

[Erratum to “Screening for alpha1-antitrypsin deficiency using dried blood spot: Assessment of the first 20 months” [Rev. Mal. Respir. 37 (2020) 633-43]]

Chapuis Cellier C, Narjoz C, Zerimech F, Odou MF, Joly P, Lombard C, Mornex JF, Balduyck M.
Rev Mal Respir. 2021 Jan;38(1):125-126. Doi: 10.1016/j.rmr.2020.11.011.

Medical algorithm: Aspergillus fumigatus components in the diagnosis of Allergic Bronchopulmonary Aspergillosis.

Lukaszewicz R, Mahay G, Boyer O, Martinet J.
Allergy. 2021 Jul 12. Doi: 10.1111/all.15001.

[Allergic Broncho-Pulmonary Aspergillosis (ABPA) in cystic fibrosis: Mechanisms, diagnosis and therapeutic options].

Bui S, Dournes G, Fayon M, Bouchet S, Burgel PR, Macey J, Murris M, Delhaes L.
Rev Mal Respir. 2021 May;38(5):466-476. Doi: 10.1016/j.rmr.2021.04.004.

[Hypersensitivity Pneumonitis: An update].

Chauvin P, Kerjouan M, Jégo P, Jouneau S, Lescoat A.
Rev Med Interne. 2021 Apr 30: S0248-8663(21)00413-6. Doi: 10.1016/j.revmed.2021.03.333.

[Hot tub lung: A retrospective analysis of 14 cases].

Messe R, Barrera C, Gondouin A, Dalphin JC.
Rev Mal Respir. 2021 Jan;38(1):13-21. Doi: 10.1016/j.rmr.2020.11.005.

MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.

Juge PA, Solomon JJ, van Moorsel CHM, Garofoli R, Lee JS, Louis-Sydney F, Rojas-Serrano J, González-Pérez MI, Mejia M, Buendia-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou KM, Sidiropoulos P, Trachalaki A, van der Vis JJ, Jamnitski A, Grutters JC, Kannengiesser C, Borie R, Kawano-Dourado L, Wemeau-Stervinou L, Flipo RM, Nunes H, Uzunhan Y, Valeyre D, Saidenberg-Kermanac’h N, Boissier MC, Richez C, Schaeverbeke T, Doyle T, Wolters PJ, Debray MP, Boileau C, Porcher R, Schwartz DA, Crestani B, Dieudé P. Semin Arthritis Rheum.
2021 Oct;51(5):996-1004. Doi: 10.1016/j.semarthrit.2021.07.002.

Diagnosis yield and safety of surgical biopsy in interstitial lung diseases: a prospective study.

Radu D, Freynet O, Kambouchner M, Boubaya M, Nunes H, Uzunhan Y, Brillet PY, Guiraudet P, Noorah MZ, Israël-Biet D, Le Pimpec-Barthes F, Juvin K, Charpentier A, Gibault L, Assouad J, Naccache JM, Antoine M, Tavolaro S, Alifano M, Honoré I, L’Huillier JP, Debrosse D, Dupin C, Pradère P, Debray MP, Cazes A, Mordant P, Castier Y, Beloucif S, Crestani B, Lévy V, Martinod E, Valeyre D.
Ann Thorac Surg. 2021 Sep 29: S0003-4975(21)01672-6. Doi: 10.1016/j.athoracsur.2021.08.056.

Methionine supplementation for multi-organ dysfunction in MetRS-related pulmonary alveolar proteinosis.

Hadchouel A, Drummond D, Pontoizeau C, Aoust L, Hurtado Nedelec MM, El Benna J, Gachelin E, Perisson C, Vigier C, Schiff M, Lacaille F, Molina TJ, Berteloot L, Renolleau S, Ottolenghi C, Tréluyer JM, de Blic J, Delacourt C.
Eur Respir J. 2021 Sep 9:2101554. Doi: 10.1183/13993003.01554-2021.

[18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach.

Tanguy J, Goirand F, Bouchard A, Frenay J, Moreau M, Mothes C, Oudot A, Helbling A, Guillemin M, Bonniaud P, Cochet A, Collin B, Bellaye PS.
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3058-3074. Doi: 10.1007/s00259-021-05209-2.

A call for evidence in connective tissue diseases-associated interstitial lung disease.

Cottin V, Lega JC, Coury F, Nasser M.
Joint Bone Spine. 2021 Sep 15;89(1):105274. Doi: 10.1016/j.jbspin.2021.105274.

Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities.

Spagnolo P, Ryerson CJ, Putman R, Oldham J, Salisbury M, Sverzellati N, Valenzuela C, Guler S, Jones S, Wijsenbeek M, Cottin V.
Lancet Respir Med. 2021 Sep;9(9):1065-1076. Doi: 10.1016/S2213-2600(21)00017-5.

The progressive fibrotic phenotype in current clinical practice.

Wells AU, Brown KK, Cottin V.
Curr Opin Pulm Med. 2021 Sep 1;27(5):368-373. Doi: 10.1097/MCP.0000000000000805.

Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France.

Cottin V, Larrieu S, Boussel L, Si-Mohamed S, Bazin F, Marque S, Massol J, Thivolet-Bejui F, Chalabreysse L, Maucort-Boulch D, Jouneau S, Hachulla E, Chollet J, Nasser M.
Front Med (Lausanne). 2021 Aug 30;8:699532. Doi: 10.3389/fmed.2021.699532.

Clinical Impact of Surgical Lung Biopsy for Interstitial Lung Disease in a Reference Center.

Le Guen P, Iquille J, Debray MP, Guyard A, Roussel A, Borie R, Dombret MC, Dupin C, Ghanem M, Taille C, Khalil A, Castier Y, Cazes A, Crestani B, Mordant P.
Ann Thorac Surg. 2021 Aug 14: S0003-4975(21)01428-4. Doi: 10.1016/j.athoracsur.2021.07.038.

Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases.

Tanguy J, Pommerolle L, Garrido C, Kolb M, Bonniaud P, Goirand F, Bellaye PS.
Int J Mol Sci. 2021 Aug 27;22(17):9316. Doi: 10.3390/ijms22179316.

Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study.

Wijsenbeek MS, Bendstrup E, Valenzuela C, Henry MT, Moor CC, Jouneau S, Fois AG, Moran-Mendoza O, Anees S, Mirt M, Bengus M, Gilberg F, Kirchgaessler KU, Vancheri C.
Adv Ther. 2021 Jul;38(7):4040-4056. Doi: 10.1007/s12325-021-01790-y.

Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?

Kalluri M, Luppi F, Vancheri A, Vancheri C, Balestro E, Varone F, Mogulkoc N, Cacopardo G, Bargagli E, Renzoni E, Torrisi S, Calvello M, Libra A, Pavone M, Bonella F, Cottin V, Valenzuela C, Wijsenbeek M, Bendstrup E; 3rd International Summit for ILD (ISILD), Erice collaborators listed below.
Eur Respir Rev. 2021 May 25;30(160):210026. Doi: 10.1183/16000617.0026-2021.

Care Delivery Models and Interstitial Lung Disease: The Role of the Specialized Center.

Fisher JH, Cottin V.
Clin Chest Med. 2021 Jun;42(2):347-355. Doi: 10.1016/j.ccm.2021.03.013.

Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.

Nathan SD, Cottin V, Behr J, Hoeper MM, Martinez FJ, Corte TJ, Keogh AM, Leuchte H, Mogulkoc N, Ulrich S, Wuyts WA, Yao Z, Ley-Zaporozhan J, Müller-Lisse UG, Scholle FD, Brüggenwerth G, Busse D, Nikkho S, Wells AU.
J Heart Lung Transplant. 2021 Jun;40(6):494-503. Doi: 10.1016/j.healun.2021.02.006.

Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).

Nasser M, Larrieu S, Boussel L, Si-Mohamed S, Bazin F, Marque S, Massol J, Thivolet-Bejui F, Chalabreysse L, Maucort-Boulch D, Hachulla E, Jouneau S, Le Lay K, Cottin V.

Respir Res. 2021 May 24;22(1):162. Doi: 10.1186/s12931-021-01749-1.

Methylprednisolone pulse treatment improves ProSP-C trafficking in twins with SFTPC mutation: An isoform story?

Delestrain C, Aissat A, Simon S, Tarze A, Duprat E, Nattes E, Costes B, Delattre V, Finet S, Fanen P, Epaud R.
Br J Clin Pharmacol. 2021 May;87(5):2361-2373. Doi: 10.1111/bcp.14645.

Impact of the COVID-19 lockdown on patients suffering from idiopathic interstitial pneumonia.

Beltramo G, Cransac A, Favrolt N, Spanjaard M, Zeller M, Cottin Y, Boulin M, Bonniaud P.
Respir Med Res. 2021 May;79:100808. Doi: 10.1016/j.resmer.2020.100808.

Sleep in children and young adults with interstitial and diffuse lung disease.

Abdel-Latif Thomasson D, Abou Taam R, Berteloot L, Khirani S, Griffon L, Hadchouel A, Delacourt C, Fauroux B.
Sleep Med. 2021 Apr;80:23-29. Doi: 10.1016/j.sleep.2021.01.020.

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases.

Cottin V, Richeldi L, Rosas I, Otaola M, Song JW, Tomassetti S, Wijsenbeek M, Schmitz M, Coeck C, Stowasser S, Schlenker-Herceg R, Kolb M; INBUILD Trial Investigators.
Respir Res. 2021 Mar 16;22(1):84. doi: 10.1186/s12931-021-01668-1.

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study).

Nasser M, Larrieu S, Si-Mohamed S, Ahmad K, Boussel L, Brevet M, Chalabreysse L, Fabre C, Marque S, Revel D, Thivolet-Bejui F, Traclet J, Zeghmar S, Maucort-Boulch D, Cottin V.
Eur Respir J. 2021 Feb 11;57(2):2002718. Doi: 10.1183/13993003.02718-2020.

Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey.

Olson A, Hartmann N, Patnaik P, Wallace L, Schlenker-Herceg R, Nasser M, Richeldi L, Hoffmann-Vold AM, Cottin V.
Adv Ther. 2021 Feb;38(2):854-867. Doi: 10.1007/s12325-020-01578-6.

Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.

Legendre M, Butt A, Borie R, Debray MP, Bouvry D, Filhol-Blin E, Desroziers T, Nau V, Copin B, Dastot-Le Moal F, Héry M, Duquesnoy P, Allou N, Bergeron A, Bermudez J, Cazes A, Chene AL, Cottin V, Crestani B, Dalphin JC, Dombret C, Doray B, Dupin C, Giraud V, Gondouin A, Gouya L, Israël-Biet D, Kannengiesser C, Le Borgne A, Leroy S, Longchampt E, Lorillon G, Nunes H, Picard C, Reynaud-Gaubert M, Traclet J, de Vuyst P, Coulomb L’Hermine A, Clement A, Amselem S, Nathan N.
Eur Respir J. 2020 Dec 24;56(6):2002806. Doi: 10.1183/13993003.02806-2020.

How to Tackle the Diagnosis and Treatment in the Diverse Scenarios of Extrapulmonary Sarcoidosis.

Valeyre D, Jeny F, Rotenberg C, Bouvry D, Uzunhan Y, Sève P, Nunes H, Bernaudin JF.
Adv Ther. 2021 Sep;38(9):4605-4627. Doi: 10.1007/s12325-021-01832-5.

Drug-induced sarcoidosis-like reactions.

Miedema J, Nunes H.
Curr Opin Pulm Med. 2021 Sep 1;27(5):439-447. Doi: 10.1097/MCP.0000000000000800.

Hypoxia Promotes a Mixed Inflammatory-Fibrotic Macrophages Phenotype in Active Sarcoidosis.

Jeny F, Bernaudin JF, Valeyre D, Kambouchner M, Pretolani M, Nunes H, Planès C, Besnard V.
Front Immunol. 2021 Aug 11;12:719009. Doi: 10.3389/fimmu.2021.719009.

Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.

Pacheco Y, Valeyre D, El Jammal T, Vallee M, Chevalier F, Lamartine J, Sigaudo-Roussel D, Verrier B, Israel-Biet D, Freymond N, Cottin V, Calender A.
Cells. 2021 Aug 5;10(8):1995. Doi: 10.3390/cells10081995.

Lung transplantation for sarcoidosis: outcome and prognostic factors.

Le Pavec J, Valeyre D, Gazengel P, Holm AM, Schultz HH, Perch M, Le Borgne A, Reynaud-Gaubert M, Knoop C, Godinas L, Hirschi S, Bunel V, Laporta R, Harari S, Blanchard E, Magnusson JM, Tissot A, Mornex JF, Picard C, Savale L, Bernaudin JF, Brillet PY, Nunes H, Humbert M, Fadel E, Gottlieb J.
Eur Respir J. 2021 Aug 5;58(2):2003358. Doi: 10.1183/13993003.03358-2020.

ERS clinical practice guidelines on treatment of sarcoidosis.

Baughman RP, Valeyre D, Korsten P, Mathioudakis AG, Wuyts WA, Wells A, Rottoli P, Nunes H, Lower EE, Judson MA, Israel-Biet D, Grutters JC, Drent M, Culver DA, Bonella F, Antoniou K, Martone F, Quadder B, Spitzer G, Nagavci B, Tonia T, Rigau D, Ouellette DR.
Eur Respir J. 2021 Jun 17:2004079. Doi: 10.1183/13993003.04079-2020.

Sarcoidosis-Like Cancer-Associated Granulomatosis: Characteristics and a Case-Control Comparison with Sarcoidosis.

Pastré J, Bouvry D, Juvin K, Benattia A, Annesi-Maesano I, Valeyre D, Nunes H, Israël-Biet D.
J Clin Med. 2021 May 5;10(9):1988. Doi: 10.3390/jcm10091988.

Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort.

Lhote R, Annesi-Maesano I, Nunes H, Launay D, Borie R, Sacré K, Schleinitz N, Hamidou M, Mahevas M, Devilliers H, Bonniaud P, Lhote F, Haroche J, Rufat P, Amoura Z, Valeyre D, Cohen Aubart F.
Eur Respir J. 2021 Apr 1;57(4):2001160. Doi: 10.1183/13993003.01160-2020.